{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:29:27Z","timestamp":1767850167875,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31170871"],"award-info":[{"award-number":["31170871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31370929"],"award-info":[{"award-number":["31370929"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chinese Academy of Sciences, and \u201cChina 863 program\u201d","award":["2014AA021003"],"award-info":[{"award-number":["2014AA021003"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.066","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T21:34:05Z","timestamp":1472679245000},"page":"4875-4883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1"],"prefix":"10.1016","volume":"34","author":[{"given":"Tao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.066_b0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/viro.1999.9820","article-title":"Genetic characterization of the pathogenic influenza A\/Goose\/Guangdong\/1\/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong","volume":"261","author":"Xu","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.08.066_b0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(98)01182-9","article-title":"Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus","volume":"351","author":"Yuen","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.08.066_b0015","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(03)14854-4","article-title":"Influenza","volume":"362","author":"Nicholson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.08.066_b0020","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1099\/vir.0.82939-0","article-title":"Molecular and antigenic evolution and geographical spread of H5N1 highly pathogenic avian influenza viruses in western Africa","volume":"88","author":"Ducatez","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0025","unstructured":"Organization WH. Cumulative number of confirmed human cases of avian influenza A\/(H5N1) reported to WHO. <http:\/\/www.who.int\/influenza\/human_animal_interface\/EN_GIP_20151214cumulativeNumberH5N1cases.pdf?ua=1>."},{"key":"10.1016\/j.vaccine.2016.08.066_b0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa044021","article-title":"Probable person-to-person transmission of avian influenza A (H5N1)","volume":"352","author":"Ungchusak","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2016.08.066_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/nature10831","article-title":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets","volume":"486","author":"Imai","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.08.066_b0040","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"Herfst","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.08.066_b0045","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/infdis\/jiu123","article-title":"A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response","volume":"209","author":"Talaat","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.066_b0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/viro.2002.1742","article-title":"Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics","volume":"305","author":"Subbarao","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.08.066_b0055","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1128\/JVI.06930-11","article-title":"A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses","volume":"86","author":"Zhou","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(06)68076-8","article-title":"Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice","volume":"367","author":"Hoelscher","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.08.066_b0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/08830180802295765","article-title":"Development of a vaccine against pandemic influenza viruses: current status and perspectives","volume":"27","author":"Ilyinskii","year":"2008","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0070","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/14712598.2010.519332","article-title":"Production of adenovirus vectors and their use as a delivery system for influenza vaccines","volume":"10","author":"Vemula","year":"2010","journal-title":"Exp Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2016.08.066_b0075","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1128\/JVI.80.4.1959-1964.2006","article-title":"Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization","volume":"80","author":"Gao","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0080","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.vaccine.2004.02.040","article-title":"Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus","volume":"22","author":"Wesley","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.066_b0085","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.vaccine.2004.07.043","article-title":"Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans","volume":"23","author":"Van Kampen","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.066_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2014.30","article-title":"Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China","volume":"3","author":"Wang","year":"2014","journal-title":"Emerg Microbes Infec"},{"key":"10.1016\/j.vaccine.2016.08.066_b0095","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.1128\/JVI.78.23.13207-13215.2004","article-title":"Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5","volume":"78","author":"Holterman","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0100","doi-asserted-by":"crossref","first-page":"e0122835","DOI":"10.1371\/journal.pone.0122835","article-title":"Heterologous prime-boost regimens with a recombinant chimpanzee adenoviral vector and adjuvanted F4 protein elicit polyfunctional HIV-1-specific T-Cell responses in macaques","volume":"10","author":"Lorin","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.066_b0105","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2005.10.042","article-title":"Chimpanzee adenovirus vaccine protects against Zaire Ebola virus","volume":"346","author":"Kobinger","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.08.066_b0110","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/876314","article-title":"Influenza virus specific CD8(+) T cells exacerbate infection following high dose influenza challenge of aged mice","author":"Parzych","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.vaccine.2016.08.066_b0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/gt.2015.31","article-title":"Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge","volume":"22","author":"Zhang","year":"2015","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2016.08.066_b0120","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1038\/mt.2010.202","article-title":"A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge","volume":"18","author":"Zhou","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2016.08.066_b0125","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/nprot.2010.134","article-title":"An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector","volume":"5","author":"Zhou","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2016.08.066_b0130","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1128\/JVI.75.23.11603-11613.2001","article-title":"Replication-defective vector based on a chimpanzee adenovirus","volume":"75","author":"Farina","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0135","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1128\/JVI.73.3.2094-2098.1999","article-title":"DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice","volume":"73","author":"Kodihalli","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0140","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1128\/JVI.00976-15","article-title":"Repeated low-dose influenza virus infection causes severe disease in mice: a model for vaccine evaluation","volume":"89","author":"Song","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0145","first-page":"8","article-title":"A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection","author":"Du","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.066_b0150","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/JVI.72.6.5146-5153.1998","article-title":"Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages","volume":"72","author":"La Linn","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0155","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199605023341809","article-title":"Adenoviruses as gene-delivery vehicles","volume":"334","author":"Wilson","year":"1996","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2016.08.066_b0160","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.170.3.1416","article-title":"A simian replication-defective vaccine to HIV-1 gag","volume":"170","author":"Fitzgerald","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0165","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.08.066_b0170","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-6-S3-P398","article-title":"A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag\/pol\/nef vaccine in the STEP trial","volume":"6","author":"Fellay","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.vaccine.2016.08.066_b0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/0022-1317-83-1-151","article-title":"Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor","volume":"83","author":"Cohen","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.gt.3302675","article-title":"Chimpanzee-origin adenovirus vectors as vaccine carriers","volume":"13","author":"Tatsis","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2016.08.066_b0185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/viro.2002.1742","article-title":"Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics","volume":"305","author":"Subbarao","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.08.066_b0190","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.vaccine.2015.01.070","article-title":"Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies","volume":"33","author":"Roos","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.066_b0195","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1128\/JVI.02497-06","article-title":"Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors","volume":"81","author":"McCoy","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/273238a0","article-title":"Transfer of specific cytotoxic T-lymphocytes protects mice inoculated with influenza-virus","volume":"273","author":"Yap","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.08.066_b0205","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.066_b0210","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4049\/jimmunol.158.4.1507","article-title":"MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL","volume":"158","author":"Deng","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.08.066_b0215","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.clpt.6100418","article-title":"New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice","volume":"82","author":"Hoelscher","year":"2007","journal-title":"Clin Pharmacol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16307629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T22:33:44Z","timestamp":1692484424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16307629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":43,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16307629"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}